Mediators and Patterns of Muscle Loss in Chronic Systemic Inflammation

作者: Sandra Pérez-Baos , Iván Prieto-Potin , Jorge A. Román-Blas , Olga Sánchez-Pernaute , Raquel Largo

DOI: 10.3389/FPHYS.2018.00409

关键词: InflammationSystemic inflammationJanus kinaseCell biologySkeletal muscleSTAT proteinMyokineMedicineMyocyteSarcopenia

摘要: Besides its primary function in locomotion, skeletal muscle (SKM), which represents up to half of human’s weight, also plays a fundamental homeostatic role. Through the secretion soluble peptides, or myokines, SKM interacts with major organs involved metabolic processes. In turn, cues from these are received by cells, adapt their response accordingly. This is done through an intricate intracellular signaling network characterized cross-talking between anabolic and catabolic pathways. A fine regulation required protect organism excessive energy expenditure. Systemic inflammation evokes reaction known as sarcopenia. turn this comprises several mechanisms, vary depending on nature insult magnitude. regard, aging, chronic inflammatory systemic diseases, osteoarthritis idiopathic myopathies can lead loss. Interestingly, sarcopenia may persist despite remission inflammation, issue warrants further research. The Janus kinase/signal transducer activator transcription (JAK/STAT) system stands participant loss during while it well-recognized orchestrator cell turnover. Herein we summarize current knowledge about models sarcopenia, triggers mediators effect both protein growth yields. Also, dual action JAK/STAT pathway mass changes discussed. We highlight need unravel precise contribution order design targeted therapeutic strategies.

参考文章(161)
Roubenoff R, Holland Sm, Hellmann Db, Ward Lm, Roubenoff Ra, Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. The Journal of Rheumatology. ,vol. 19, pp. 1505- 1510 ,(1992)
Hui-Xia Li, Kun-Lin Chen, Hai-Yang Wang, Chang-Bo Tang, Xing-Lian Xu, Guang-Hong Zhou, Chemerin inhibition of myogenesis and induction of adipogenesis in C2C12 myoblasts. Molecular and Cellular Endocrinology. ,vol. 414, pp. 216- 223 ,(2015) , 10.1016/J.MCE.2015.07.006
Esther E Dupont-Versteegden, Apoptosis in skeletal muscle and its relevance to atrophy World Journal of Gastroenterology. ,vol. 12, pp. 7463- 7466 ,(2006) , 10.3748/WJG.V12.I46.7463
Thomas Jostock, Jürgen Müllberg, Suat Özbek, Raja Atreya, Guido Blinn, Nicole Voltz, Martina Fischer, Markus F. Neurath, Stefan Rose-John, Soluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses FEBS Journal. ,vol. 268, pp. 160- 167 ,(2001) , 10.1046/J.1432-1327.2001.01867.X
I. Loell, I. E. Lundberg, Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies? Journal of Internal Medicine. ,vol. 269, pp. 243- 257 ,(2011) , 10.1111/J.1365-2796.2010.02334.X
FI Romero, MJ Martínez-Calatrava, O Sánchez-Pernaute, O Gualillo, R Largo, G Herrero-Beaumont, Pharmacological modulation by celecoxib of cachexia associated with experimental arthritis and atherosclerosis in rabbits British Journal of Pharmacology. ,vol. 161, pp. 1012- 1022 ,(2010) , 10.1111/J.1476-5381.2010.00957.X
Wayne E. Taylor, Shalender Bhasin, Jorge Artaza, Frances Byhower, Mohd Azam, Darril H. Willard, Frederick C. Kull, Nestor Gonzalez-Cadavid, Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. American Journal of Physiology-endocrinology and Metabolism. ,vol. 280, ,(2001) , 10.1152/AJPENDO.2001.280.2.E221
Fred R. Sattler, Growth hormone in the aging male Best Practice & Research Clinical Endocrinology & Metabolism. ,vol. 27, pp. 541- 555 ,(2013) , 10.1016/J.BEEM.2013.05.003
David J. Glass, Signalling pathways that mediate skeletal muscle hypertrophy and atrophy Nature Cell Biology. ,vol. 5, pp. 87- 90 ,(2003) , 10.1038/NCB0203-87